AMRN Amarin Corporation plc
$12.75▲ +6.65%
Healthcare
Other
Volume 161.3K
Avg Volume (10D) 70.7K
Key Metrics & Fundamentals
Market Cap
$269.21M
P/E Ratio
–
Div Yield
0.00%
52W Range
11.25 - 17.31
% vs 50 MA
-2.26%
% vs 200 MA
-11.12%
RSI-14
58.9
MACD Histogram
+0.1600
Beta (1Y vs SPY)
0.36
Free Cash Flow
$6.60M
Gross Rev
$42.21M
Gross Profit
$14.99M
EBITDA
-$11.29M
COGS
$27.22M
Operating Exp
$26.96M
Operating Income
-$11.97M
EBIT
-$11.97M
Pretax Income
-$7.87M
Net Income
-$7.65M
EPS (Diluted)
-0.40
Price & Volume History
Loading chart…
Recent News
Amarin Corp PLC (AMRN) Q3 2026 Earnings Call Highlights: First Profitable Quarter in Two Years ...
GuruFocus.com · Oct 28, 2026 3:06 PM ET
Amarin: Q3 Earnings Snapshot
Associated Press · Oct 28, 2026 2:36 PM ET
Amarin (AMRN) Q3 2026 Earnings Call Transcript
Motley Fool · Oct 28, 2026 12:42 PM ET
Amarin Returns to Quarterly Profit as Cost Reductions Offset 20% Revenue Decline
InvestorsHub · Oct 28, 2026 12:02 PM ET
European Equities Traded in the US as American Depositary Receipts Steady in Wednesday Trading
MT Newswires · Oct 28, 2026 11:15 AM ET
What Amarin (AMRN) Said on Its Q3 Earnings Call
MarketBeat · Oct 28, 2026 10:04 AM ET
Amarin Reports 2026 Third Quarter Financial Results, Achieves Positive Net Income
GlobeNewswire · Oct 28, 2026 7:00 AM ET
Amarin Provides Update on University of Leeds Sponsored Phase 3 EPA for Metastasis Trial 2 (EMT2) Evaluating VAZKEPA®/VASCEPA® (icosapent ethyl) Capsules on Top of Standard of Care Treatment in Patients Undergoing Liver Resection for Colorectal Cancer Liver Metastases (CRCLM)
GlobeNewswire · Oct 25, 2026 8:11 AM ET
Amarin to Report Third Quarter 2026 Financial Results and Host Conference Call on October 28, 2026
GlobeNewswire · Oct 21, 2026 8:00 AM ET
European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading
MT Newswires · Oct 19, 2026 11:13 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See AMRN's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.